Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Seda Ghazaryan"'
Publikováno v:
PLoS ONE, Vol 9, Iss 6, p e99525 (2014)
Despite all the blood-based biomarkers used to monitor prostate cancer patients, prostate cancer remains as the second common cause of cancer mortality in men in the United States. This is largely due to a lack of understanding of the molecular pathw
Externí odkaz:
https://doaj.org/article/be6aec0d42a542f6a8a764e722eac1ca
Autor:
Frank Westermann, Manfred Schwab, Paul Gillespie, Volker Ehemann, Kai-Oliver Henrich, Matthias Fischer, Sina Gogolin, Claudia Beisel, Julia Batzler, Christina Pöhler, Emily Beckett, Isabella Eckerle, Seda Ghazaryan, Daniel Muth
Supplementary Table 1 from Transcriptional Repression of SKP2 Is Impaired in MYCN-Amplified Neuroblastoma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::822934ae0d0709875bea5f3ee072b3ad
https://doi.org/10.1158/0008-5472.22382321.v1
https://doi.org/10.1158/0008-5472.22382321.v1
Autor:
Frank Westermann, Manfred Schwab, Paul Gillespie, Volker Ehemann, Kai-Oliver Henrich, Matthias Fischer, Sina Gogolin, Claudia Beisel, Julia Batzler, Christina Pöhler, Emily Beckett, Isabella Eckerle, Seda Ghazaryan, Daniel Muth
Supplementary Figure 1 from Transcriptional Repression of SKP2 Is Impaired in MYCN-Amplified Neuroblastoma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a02e86772657bd0ff4babbe3c0269c10
https://doi.org/10.1158/0008-5472.22382333.v1
https://doi.org/10.1158/0008-5472.22382333.v1
Autor:
Frank Westermann, Manfred Schwab, Paul Gillespie, Volker Ehemann, Kai-Oliver Henrich, Matthias Fischer, Sina Gogolin, Claudia Beisel, Julia Batzler, Christina Pöhler, Emily Beckett, Isabella Eckerle, Seda Ghazaryan, Daniel Muth
The cell cycle regulator, SKP2, is overexpressed in various cancers and plays a key role in p27 degradation, which is involved in tumor cell dedifferentiation. Little is known about the mechanisms leading to impaired SKP2 transcriptional control in t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0eb6176f8e9d5faecba326e16feb4c89
https://doi.org/10.1158/0008-5472.c.6500168.v1
https://doi.org/10.1158/0008-5472.c.6500168.v1
Publikováno v:
Blood. 119:4532-4542
The retinoblastoma (Rb) tumor suppressor plays important roles in regulating hematopoiesis, particularly erythropoiesis. In an effort to understand whether Rb function can be mediated by E2F transcription factors in a BM-derived hematopoietic system
Autor:
Rene Opavsky, Seda Ghazaryan, Lizhao Wu, Xiuli An, Narla Mohandas, Haiqing Fu, Tinghui Hu, Chandler B. Sy, Mirit I. Aladjem, Victor T. Chang
Publikováno v:
Molecular and cellular biology. 34(15)
Rb is critical for promoting cell cycle exit in cells undergoing terminal differentiation. Here we show that during erythroid terminal differentiation, Rb plays a previously unappreciated and unorthodox role in promoting DNA replication and cell cycl
Autor:
Emily Beckett, Kai Oliver Henrich, Matthias Fischer, Isabella Eckerle, Daniel Muth, Sina Gogolin, Paul Gillespie, Frank Westermann, Julia Batzler, Christina Pöhler, Volker Ehemann, Manfred Schwab, Seda Ghazaryan, Claudia Beisel
Publikováno v:
Cancer research. 70(9)
The cell cycle regulator, SKP2, is overexpressed in various cancers and plays a key role in p27 degradation, which is involved in tumor cell dedifferentiation. Little is known about the mechanisms leading to impaired SKP2 transcriptional control in t
Autor:
Gayane Avetisyan, Constanze Karst, Hasmik Mkrtchyan, Anna Hovhannisyan, Madeleine Gross, Thomas Liehr, Smbat Daghbashyan, Laura Muradyan, Sophie Hinreiner, Rouben Aroutiounian, Seda Ghazaryan
Publikováno v:
Oncology Reports.
The fusion gene BCR/ABL arises in connection with a complex translocation event in 2-10% of cases with chronic myeloid leukemia (CML). Due to causative treatment with Imatinib most cases with variant rearrangements show no specific prognostic signifi
Publikováno v:
PLoS ONE
PLoS ONE, Vol 9, Iss 6, p e99525 (2014)
PLoS ONE, Vol 9, Iss 6, p e99525 (2014)
Despite all the blood-based biomarkers used to monitor prostate cancer patients, prostate cancer remains as the second common cause of cancer mortality in men in the United States. This is largely due to a lack of understanding of the molecular pathw